Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > CHTT > Summary

Chattem Inc.
(CHTT)

67.01USD   Down 0.61 (0.90%)   
On Nov 26
 Chattem Inc. (NasdaqNM:CHTT) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 67.01USD
Trade Time:Nov 26
Change:Down 0.61 (0.90%) 
Prev Close:67.62
Open:67.60
Bid:65.13 x 100
Ask:68.95 x 100
1y Target Est:71.44
Day's Range:66.98 - 67.52
52wk Range:50.10 - 72.93
Volume:85,120
Avg Vol (3m):232,547
Market Cap:1.28B
P/E (ttm):15.42
EPS (ttm):4.35
Div & Yield:N/A (N/A%)
Add CHTT to Portfolio   Download Data

HEADLINES

 
•Forbes Best Small Companies for 2009: Part III - Seeking Alpha  - Sun, Nov 22
•Cramer's Mad Money - The Fastest Growing Drug Company (10/9/09) - Seeking Alpha  - Sun, Oct 11
•Drug Deal Offers Big Bennies to This Biz - CNBC  - Sat, Oct 10
•Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 3) - TheStreet.com  - Sat, Oct 10
•[video] Rx For Profits? - CNBC  - Sat, Oct 10
•CHATTEM INC Financials - EDGAR Online Financials  - Fri, Oct 9
•New Star Analyst Rankings for Chattem, Inc. - StarMine  - Wed, Oct 7
•Chattem Cuts Costs To Offset Sales Miss - Barrons.com  - Tue, Oct 6
•Chattem Inc Earnings Call scheduled for 8:30 am ET today - CCBN  - Tue, Oct 6
•Chattem 3Q profit up on sales boost, lower costs - AP  - Tue, Oct 6
•CHATTEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - EDGAR Online  - Tue, Oct 6
•Chattem Reports Increased Revenues and Earnings; Affirms Fiscal 2009 Guidance - Business Wire  - Tue, Oct 6
•Q3 2009 Chattem Inc Earnings Release - Before Market Open - CCBN  - Tue, Oct 6
» More Headlines for CHTT...

ANALYST

 
EPS Est (next year) (Nov-09) :4.57
EPS Est (in 2 years) (Nov-10) :5.03
Avg Rec (current)*:2.1
PEG Ratio:1.30
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Chattem, Inc., together with its subsidiaries, engages in the manufacture and marketing of over-the-counter (OTC) healthcare products, toiletries, and dietary supplements.

» Full Company Profile